Ncs2* mediates in vivo virulence of pathogenic yeast through sulphur modification of cytoplasmic transfer RNA.
Options
BORIS DOI
Date of Publication
August 25, 2023
Publication Type
Article
Division/Institute
Contributor
Alings, Fiona | |
Scharmann, Karin | |
Böttcher, Bettina | |
Sokołowski, Mikołaj | |
Roth, Joël | |
Glatt, Sebastian | |
Brunke, Sascha |
Series
Nucleic acids research
ISSN or ISBN (if monograph)
1362-4962
Publisher
Oxford University Press
Language
English
Publisher DOI
PubMed ID
37462076
Description
Fungal pathogens threaten ecosystems and human health. Understanding the molecular basis of their virulence is key to develop new treatment strategies. Here, we characterize NCS2*, a point mutation identified in a clinical baker's yeast isolate. Ncs2 is essential for 2-thiolation of tRNA and the NCS2* mutation leads to increased thiolation at body temperature. NCS2* yeast exhibits enhanced fitness when grown at elevated temperatures or when exposed to oxidative stress, inhibition of nutrient signalling, and cell-wall stress. Importantly, Ncs2* alters the interaction and stability of the thiolase complex likely mediated by nucleotide binding. The absence of 2-thiolation abrogates the in vivo virulence of pathogenic baker's yeast in infected mice. Finally, hypomodification triggers changes in colony morphology and hyphae formation in the common commensal pathogen Candida albicans resulting in decreased virulence in a human cell culture model. These findings demonstrate that 2-thiolation of tRNA acts as a key mediator of fungal virulence and reveal new mechanistic insights into the function of the highly conserved tRNA-thiolase complex.
File(s)
File | File Type | Format | Size | License | Publisher/Copright statement | Content | |
---|---|---|---|---|---|---|---|
gkad564.pdf | text | Adobe PDF | 2.81 MB | published |